Victoria A. Jenkins
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: April 16, 2026
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: February 04, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: February 04, 2025
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine.
Journal: The Journal of infectious diseases
Published: December 05, 2022
Considering the market share of vaccines against tick-borne encephalitis reported in Austria.
Journal: Journal of travel medicine
Published: February 08, 2022
The epidemiology of infectious diseases in Europe in 2020 versus 2017-2019 and the rise of tick-borne encephalitis (1995-2020).
Journal: Ticks and tick-borne diseases
Published: October 26, 2021
Letter to the editor for: Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Journal: Ticks and tick-borne diseases
Published: September 03, 2021
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
Journal: Expert review of vaccines
Published: August 11, 2020
Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis.
Journal: Human vaccines & immunotherapeutics
Published: July 24, 2020
Pertussis in high-risk groups: an overview of the past quarter-century.
Journal: Human vaccines & immunotherapeutics
Published: April 17, 2020
Last Updated: 09/26/2026